The largest database of trusted experimental protocols

7 protocols using mir 16 5p mimic

1

Overexpression and Knockdown of Key Regulators in RCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pcDNA3.1 vectors containing full length SPTLC1 were obtained from RioBio (Guangzhou, China). The miR-16–5p mimics and negative control were generated from GenePharma (Shanghai, China). Two short hairpin RNAs (shRNAs) against E2F2 (shE2F2#1 and shE2F2#2) or negative control (sh-NC) were generated from GenePharma (Shanghai, China). RCC cells were seeded in 6-well plates for 24 h. All oligonucleotides and plasmids were transfected in RCC cells by Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) for maintaining 48 h, according to the manufacturer's instructions. Stable cell lines were then obtained by treatment with 2 μg/mL puromycin (Sigma, St. Louis, MO, USA) for one week.
+ Open protocol
+ Expand
2

Modulation of Chordoma Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
siSmad3, scrambled negative control siRNA, miR-16-5p mimics and negative control were obtained from GenePharma (Suzhou, Jiangsu, China). Chordoma cells were transfected with siRNA, miR-16-5p mimics and their negative control by Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions. The final concentration of miRNA mimics was 100 nM, and the final concentration of siRNA was 20 nM.
The sequence of mature miR for miR-16-5p is 5′-UAGCAGCACGUAAAUAUUGGCG-3′, and the negative control is 5′-UUCUCCGAACGUGUCACGUTT-3′. The sense sequence of Smad3 siRNA is 5′-CCGCAUGAGCUUCGUCAAATT-3′, and the antisense sequence is 5′-UUUGACGAAGCUCAUGCGGTT-3′. The negative control siRNA sequences are 5′-UUCUCCGAACGUGUCACGUTT-3′ and 5′-ACGUGACACGUUCGGAGAATT-3′.
+ Open protocol
+ Expand
3

Overexpression and Inhibition of miR-16-5p

Check if the same lab product or an alternative is used in the 5 most similar protocols
G6PD overexpression plasmid and miR-16-5p mimic were designed and synthesized by GenePharma (Shanghai, China). miR-NC inhibitor: 5ʹ-UAGCAGCACGUAAAUAUUGGCG-3ʹ; miR-NC mimic: 5ʹ-GGAACUUAGCCACUGUGAAUU-3ʹ; miR-16-5p mimic: 5ʹ-UUCUCCGAACGUGUCACGUTT-3ʹ. Lentiviral short hairpin RNA targeting ZBTB16 (si-ZBTB16) and its negative control, were produced by Genechem (Shanghai, China). Cells were transfected with designated plasmids by employing Lipofectamine 2000 (Invitrogen, USA).
+ Open protocol
+ Expand
4

Validating miR-16-5p Binding Site in FOXK1

Check if the same lab product or an alternative is used in the 5 most similar protocols
StarBase (http://starbase.sysu.edu.cn/) was utilized to predict the binding site of miR-16-5p to FOXK1. The mutant (mut) and wild-type (wt) sequences containing the binding sites of miR-16-5p to FOXK1 (mut-FOXK1 and wt-FOXK1) were designed and synthesized based on the predicted results and cloned into luciferase reporter vectors (pGL3-Basic). Thereafter, the designed sequences were co-transfected with miR-16-5p mimic (0, 150, 300 nM, GenePharma) into HEK293T cells, respectively. After that, cells received 20-min cell lysing with 100 μL cell lysis buffer on a shaking table at room temperature. Firefly luciferase activity or Renilla luciferase activity was measured after the exposure of cell suspension (50 μL) to luciferase reaction solution (50 μL, Promega, Madison, WI, USA) or Stop & Glo reagent (50 μL, Promega). The relative activity was calculated as the ratio of Firefly luciferase activity to Renilla luciferase activity. Renilla luciferase activity was regarded as an internal control. Three replicates were set for this test.
+ Open protocol
+ Expand
5

Regulation of Osteosarcoma Cell Behavior by miR-16-5p

Check if the same lab product or an alternative is used in the 5 most similar protocols
The siRNA targeting Smad3, scrambled negative control (NC) siRNA, miR-16-5p mimic, miR-NC, miR-16-5p inhibitor, and NC inhibitor were obtained from GenePharma (Suzhou, Jiangsu, China). MG63 and HOS cells were transfected with siRNA, miR-16-5p mimic, miR-NC, miR-16-5p inhibitor, and NC inhibitor using Lipofectamine 3000 (Invitrogen), as per the manufacturer’s instructions. The final concentrations of miRNA mimic and siRNA were 100 and 20 nM, respectively.
The sequences were as follows:
miR-16-5p mimic: 5′-UAGCAGCACGUAAAUAUUGGCG-3′
miR-16-5p inhibitor: 5′-CACCAAUAUUUACGUGCUGCUA-3′
miR-NC: 5′-UUCUCCGAACGUGUCACGUTT-3′
Smad3 siRNA: 5′-CCGCAU GAGCUUCGUCAAATT-3′
+ Open protocol
+ Expand
6

Silencing circUSP34 via miR-16-5p mimic

Check if the same lab product or an alternative is used in the 5 most similar protocols
KHOS and 143B cells were cultured in six‐well plates (8 × 105 cells per well) to 70%‐80% confluence before transfection. miR‐16‐5p mimic and negative control were synthesized by GenePharma. Lentivirus, the sh‐circUSP34 vector #1 and #2, was constructed targeting the specific head‐to‐tail junction site purchased from Hanbio Biotechnology Company. Sequences of mimic, inhibitor, and vectors are listed in Table 2. Lipofectamine 3000 (Invitrogen) and Polybrene (Hanbio Biotechnology Company) were applied to facilitate miR‐16‐5p mimic and sh‐circUSP34 complex formation, respectively.
+ Open protocol
+ Expand
7

miR-16-5p Regulation in HRECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to transfection, 1×10 6 of HRECs were seeded into a 6-well plate. The cell monolayer was ~80% confluent at the time of transfection. miR-16-5p inhibitor, its negative control (inhibitor NC), miR-16-5p mimic and the mimic NC were provided by GenePharma (Shanghai, China). Transfection experiments were conducted using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the standard protocol. Cells were collected 48 h after transfection, the success of which was evaluated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!